These programs have largely been unsuccessful because they were unable to break the sylvatic cycle involving wild primates. With few countries establishing regular vaccination programs, measures to fight yellow fever have been neglected, making the future spread of the virus more likely. Research
In the hamster model of yellow fever, early administration of the antiviral ribavirin is an effective treatment of many pathological features of the disease. Ribavirin treatment during the first five days after virus infection improved survival rates, reduced tissue damage in the liver and spleen, prevented hepatocellular steatosis, and normalised levels of alanine aminotransferase, a liver damage marker. The mechanism of action of ribavirin in reducing liver pathology in yellow fever virus infection may be similar to its activity in treatment of hepatitis C, a related virus. Because ribavirin had failed to improve survival in a virulent rhesus model of yellow fever infection, it had been previously discounted as a possible therapy. Infection was reduced in mosquitoes with the wMel strain of Wolbachia.Yellow fever has been researched by several countries as a potential biological weapon. Notes
References
Further reading
External links

Yellow fever at Curlie
Finlay CJ (January 2012). "The Mosquito Hypothetically Considered as the Transmitting Agent of Yellow Fever". MEDICC Review. 14 (1): 56–59. doi:10.37757/MR2012V14.N1.10. PMID 34503309. "U.S. Army Yellow Fever Commission." Claude Moore Health Sciences Library, University of Virginia
"Yellow fever virus". NCBI Taxonomy Browser. 11089.
In pathology, diastasis is the separation of parts of the body that are normally joined, such as the separation of certain abdominal muscles during pregnancy, or of adjacent bones without fracture. See also
Diastasis recti
Diastasis symphysis pubisCompare with:

Diastasis (physiology)


== References ==